Analysts Offer Predictions for MLYS Q2 Earnings
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) – Stock analysts at Lifesci Capital issued their Q2 2025 earnings per share estimates for shares of Mineralys Therapeutics in a report issued on Tuesday, June 17th. Lifesci Capital analyst R. Katkhuda expects that the company will earn ($0.81) per share for the quarter. The consensus estimate for […]
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) – Stock analysts at Lifesci Capital issued their Q2 2025 earnings per share estimates for shares of Mineralys Therapeutics in a report issued on Tuesday, June 17th. Lifesci Capital analyst R. Katkhuda expects that the company will earn ($0.81) per share for the quarter. The consensus estimate for […]
